SCHEMBL13005288

SCHEMBL13005288

CCOC(=O)c1cc(OC(C)=O)c2ccc(Br)cc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
BCL2L1 Q07817 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRB1 P18505 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRB2 P47870 1/20 0.43
MAPT P10636 2/20 0.42
ATM Q13315 1/20 0.42
LMNA P02545 2/20 0.41
TBK1 Q9UHD2 1/20 0.41
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA7 P43166 3/20 0.41
CA9 Q16790 3/20 0.41
CA14 Q9ULX7 3/20 0.41
HSD17B2 P37059 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.40
ELANE P08246 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2390084 0.90 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2BCL2L1GABRA1GABRB1
SCHEMBL3330717 0.87 BCL2L1 (0.45) ALDH1A1SMN1; SMN2BCL2L1MAPTLMNA
SCHEMBL15774677 0.87 HSD17B2 (0.52) ALDH1A1SMN1; SMN2BCL2L1MAPTATM
SCHEMBL13057678 0.87 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2BCL2L1GABRA1GABRB1
SCHEMBL16479442 0.86 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2BCL2L1MAPTLMNA
SCHEMBL16474350 0.85 LMNA (0.50) ALDH1A1SMN1; SMN2BCL2L1MAPTLMNA
SCHEMBL2807973 0.85 TSHR (0.45) ALDH1A1SMN1; SMN2BCL2L1MAPTLMNA
SCHEMBL3328123 0.83 HTT (0.48) ALDH1A1SMN1; SMN2BCL2L1MAPTCA12
SCHEMBL14217542 0.82 KDM4E (0.51) ALDH1A1SMN1; SMN2MAPTLMNACA12
SCHEMBL2932838 0.81 BCL2L1 (0.53) ALDH1A1SMN1; SMN2BCL2L1GABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102652-B2 Dichroic-photochromic 2H-naphtho[1,2-b]pyran compounds and devices ALPHAMICRON INCORPORATED (US) 2015-08-11 US disclosed
US-9102652-B2 Dichroic-photochromic 2H-naphtho[1,2-b]pyran compounds and devices ALPHAMICRON INCORPORATED (US) 2015-08-11 US disclosed
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED (US) 2014-07-17 US disclosed
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED (US) 2014-07-17 US disclosed
US-20100324296-A1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED 2010-12-23 US disclosed
US-20100324296-A1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED 2010-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES NR0B2, NR0B1, DHCR24 ALDH1A1 1991/4885SMN1; SMN2 3498/4885BCL2L1 2974/4885
US-20100324296-A1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES NR0B2, NR0B1, NR2E3 ALDH1A1 1833/4885SMN1; SMN2 3654/4885BCL2L1 2376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.